Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The herbal shampoo cleans well, promotes hair growth, and improves hair quality.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Some chemotherapy can cause permanent hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Some drugs can cause changes to your hair.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

High mTORC1 activity slows hair growth and causes it to lose color.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.